SCHEMBL13428487

SCHEMBL13428487

CC(C)(C)OC(=O)NCCNc1ncc(C=O)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.54
STK17A Q9UEE5 1/20 0.54
ALDH1A1 P00352 4/20 0.44
LATS1 O95835 1/20 0.43
BCHE P06276 1/20 0.41
BRD4 O60885 3/20 0.40
MALT1 Q9UDY8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
IDO1 P14902 2/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
HSP90AA1 P07900 1/20 0.37
XBP1 P17861 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3223820 0.86 ALDH1A1 (0.51) STK17BSTK17AALDH1A1LATS1BCHE
SCHEMBL3223809 0.86 ALDH1A1 (0.51) STK17BSTK17AALDH1A1LATS1BCHE
SCHEMBL13428494 0.83 STK17B (0.54) STK17BSTK17AALDH1A1LATS1BCHE
SCHEMBL3826302 0.83 STK17B (0.54) STK17BSTK17AALDH1A1LATS1BCHE
SCHEMBL13428547 0.83 STK17B (0.47) STK17BSTK17AALDH1A1LATS1BCHE
SCHEMBL3220751 0.82 STK17B (0.50) STK17BSTK17AALDH1A1LATS1BRD4
SCHEMBL3227150 0.81 ALDH1A1 (0.50) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL19416940 0.76 TRPV1 (0.60) STK17BSTK17AALDH1A1LATS1BRD4
SCHEMBL16000816 0.76 TRPV1 (0.51) STK17BSTK17AALDH1A1LATS1BRD4
SCHEMBL13428483 0.74 CCNB2 (0.41) ALDH1A1L3MBTL1POLBKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS HDAC1, HDAC11, HDAC2 STK17B 2348/4885STK17A 1986/4885ALDH1A1 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.